SKINOVATION PHARMACEUTICAL INC Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Skinovation Pharmaceutical Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Skinovation Pharmaceutical Inc Return On Assets for the quarter ending June 30, 2024 was -386 %, a 71.7% increase year-over-year.
  • Skinovation Pharmaceutical Inc annual Return On Assets for 2023 was -418 %, a 94.3% increase from 2022.
  • Skinovation Pharmaceutical Inc annual Return On Assets for 2022 was -7.38K %, a 155% decline from 2021.
  • Skinovation Pharmaceutical Inc annual Return On Assets for 2021 was -2.9K %, a 202% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -386 +978 +71.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -388 +1.66K +81% Jan 1, 2024 Mar 31, 2024
Q4 2023 -418 +6.96K +94.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -760 +6.33K +89.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.36K +12.4K +90.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -2.05K +2.76K +57.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -7.38K -4.48K -155% Oct 1, 2022 Dec 31, 2022
Q3 2022 -7.09K -5.44K -331% Jul 1, 2022 Sep 30, 2022
Q2 2022 -13.7K -12.7K -1196% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.8K -3.95K -463% Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.9K -1.94K -202% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.65K -350 -27% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.06K +1.47K +58.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -853 +34.6K +97.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -959 +29.3K +96.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.3K +24.9K +95.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -2.53K +20.5K +89% Apr 1, 2020 Jun 30, 2020
Q1 2020 -35.5K -14.9K -72.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -30.3K -18.7K -161% Oct 1, 2019 Dec 31, 2019
Q3 2019 -26.2K -18.1K -224% Jul 1, 2019 Sep 30, 2019
Q2 2019 -23K -17.1K -291% Apr 1, 2019 Jun 30, 2019
Q1 2019 -20.5K -15K -269% Jan 1, 2019 Mar 31, 2019
Q4 2018 -11.6K -5.15K -80.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -8.08K -454 -5.96% Jul 1, 2018 Sep 30, 2018
Q2 2018 -5.9K -1.28K -27.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -5.57K -1.37K -32.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -6.42K -4.62K -256% Oct 1, 2017 Dec 31, 2017
Q3 2017 -7.62K -5.77K -311% Jul 1, 2017 Sep 30, 2017
Q2 2017 -4.62K -2.98K -181% Apr 1, 2017 Jun 30, 2017
Q1 2017 -4.2K -2.96K -239% Jan 1, 2017 Mar 31, 2017
Q4 2016 -1.8K -260 -16.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -1.85K -467 -33.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -1.64K -118 -7.73% Apr 1, 2016 Jun 30, 2016
Q1 2016 -1.24K +265 +17.6% Jan 1, 2016 Mar 31, 2016
Q4 2015 -1.54K -687 -80% Oct 1, 2015 Dec 31, 2015
Q3 2015 -1.39K -601 -76.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -1.52K -791 -108% Apr 1, 2015 Jun 30, 2015
Q1 2015 -1.5K -572 -61.4% Jan 1, 2015 Mar 31, 2015
Q4 2014 -858 +1.16K +57.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -786 +2.49K +76% Jul 1, 2014 Sep 30, 2014
Q2 2014 -731 -1.99K -158% Apr 1, 2014 Jun 30, 2014
Q1 2014 -931 -2.03K -185% Jan 1, 2014 Mar 31, 2014
Q4 2013 -2.02K -2.08K -3934% Oct 1, 2013 Dec 31, 2013
Q3 2013 -3.28K -2.56K -356% Jul 1, 2013 Sep 30, 2013
Q2 2013 1.26K +4.05K Apr 1, 2013 Jun 30, 2013
Q1 2013 1.09K +3.05K Jan 1, 2013 Mar 31, 2013
Q4 2012 52.8 Oct 1, 2012 Dec 31, 2012
Q3 2012 -719 Jul 1, 2012 Sep 30, 2012
Q2 2012 -2.79K Apr 1, 2012 Jun 30, 2012
Q1 2012 -1.96K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.